NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Tumors
Interventions: DRUG: NB1011
Sponsor: Kiadis Pharma